文献速递慢性肾脏病

反方观点:多数临床风险评分无用

Con: Most clinical risk scores are useless.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

该文指出肾脏病学及医学领域预测模型虽多,但多数因报告质量差、方法不当而未能广泛用于临床。主要问题包括候选预测变量过少或过多,且外部验证和影响研究罕见。除肾衰竭风险方程等少数例外,多数模型未经验证或报告不充分,建议研究者应更多投入验证和影响评估而非开发新模型。

要点

  • 多数预测模型因报告质量差和方法不当而无法用于临床
  • 候选预测变量过少或过多是模型性能不佳的主要原因
  • 外部验证和影响研究在肾脏病患者中罕见

核心结论

  • 多数临床风险评分模型因方法不当、报告不充分且缺乏外部验证,无法用于临床实践。
  • 除肾衰竭风险方程等少数例外,多数模型未经验证或验证不足。
  • 建议研究者更多投入现有模型的验证和影响评估,而非开发新模型。

研究设计与样本

  • 本文为论述性文章,未报告系统检索范围或样本量。

主要发现

  • 多数已发表模型报告质量差,常使用不当方法开发。
  • 主要问题为候选预测变量过少(基于单变量P<0.05)或过多(相对于事件数)。
  • 预测模型在新人群中通常表现较差,但外部验证在肾脏病患者中不常进行。
  • 影响研究显示常规临床实践中使用预测模型改善临床结局的报告罕见。

临床怎么用

  • 临床应优先使用经过外部验证的预测模型,如肾衰竭风险方程。
  • 避免使用未经验证或报告不充分的预测模型指导临床决策。

局限性

  • 本文为观点性论述,未提供系统评价或定量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While developing prediction models has become quite popular both in nephrology and in medicine in general, most models have not been implemented in clinical practice on a larger scale. This should be no surprise, as the majority of published models has been shown to be poorly reported and often developed using inappropriate methods. The main problems identified relate to either using too few candidate predictors (based on univariable P < 0.05) or too many (for the number of events), resulting in poorly performing prediction models. Guidelines on how to develop and test a prediction model all stress the importance of external validation to test discrimination and calibration in other populations, as prediction models usually perform less well in new subjects. However, external validity has not often been tested for prediction models in renal patients. Moreover, impact studies showing improved clinical outcomes when using a prediction model in routine clinical practice have been reported rarely. By and large, notwithstanding a few notable exceptions like the kidney failure risk equation prediction model, most models have not been validated externally or are at best inadequately reported, preventing them from be used in clinical practice. Therefore, we recommend researchers to spend more energy on validation and assessing the impact of existing models, instead of merely developing more models that will most likely never be used in clinical practice as well.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Dekker FW, Ramspek CL, van Diepen M, et al. Con: Most clinical risk scores are useless. Nephrol Dial Transplant. 2017. PMID: 28499028. doi:10.1093/ndt/gfx073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。